232 related articles for article (PubMed ID: 25454383)
1. [Concomitant chemoradiotherapy for muscle-invasive bladder cancer: current knowledge, controversies and future directions].
Bellefqih S; Khalil J; Mezouri I; ElKacemi H; Kebdani T; Hadadi K; Benjaafar N
Cancer Radiother; 2014 Dec; 18(8):779-89. PubMed ID: 25454383
[TBL] [Abstract][Full Text] [Related]
2. [Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology].
Quintens H; Roupret M; Larré S; Neuzillet Y; Pignot G; Compérat E; Wallerand H; Houédé N; Roy C; Soulié M; Pfister C;
Prog Urol; 2012 Jan; 22(1):13-6. PubMed ID: 22196000
[TBL] [Abstract][Full Text] [Related]
3. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.
Koga F; Kihara K
Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269
[TBL] [Abstract][Full Text] [Related]
4. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
[TBL] [Abstract][Full Text] [Related]
5. Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers.
El-Taji OM; Alam S; Hussain SA
Curr Treat Options Oncol; 2016 Mar; 17(3):15. PubMed ID: 26942590
[TBL] [Abstract][Full Text] [Related]
6. Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
Mathieu R; Lucca I; Klatte T; Babjuk M; Shariat SF
Curr Opin Urol; 2015 Sep; 25(5):476-82. PubMed ID: 26125510
[TBL] [Abstract][Full Text] [Related]
7. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A;
Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985
[TBL] [Abstract][Full Text] [Related]
8. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
[TBL] [Abstract][Full Text] [Related]
9. Organ-sparing strategies in the management of invasive bladder cancer.
Yafi FA; Cury FL; Kassouf W
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1765-75. PubMed ID: 19954288
[TBL] [Abstract][Full Text] [Related]
10. Bladder Preservation Therapy: A Review of the Literature and Future Directions.
Cahn DB; Ristau BT; Ghiraldi EM; Churilla TM; Geynisman DM; Horwitz EM; Uzzo RG; Smaldone MC
Urology; 2016 Oct; 96():54-61. PubMed ID: 27257135
[TBL] [Abstract][Full Text] [Related]
11. Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer.
Colvett KT; Althausen AF; Bassil B; Heney NM; McGovern FV; Young HH; Kaufman DS; Zietman AL; Shipley WU
J Surg Oncol; 1996 Nov; 63(3):201-8. PubMed ID: 8944067
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of bladder cancer in the elderly].
Fröhner M; Rübben H
Urologe A; 2015 Apr; 54(4):510-5. PubMed ID: 25794588
[TBL] [Abstract][Full Text] [Related]
13. The role of chemotherapy and radiation in organ-preservation strategies for muscle-invasive bladder cancer.
Bradley BA; Wajsman Z
World J Urol; 2002 Aug; 20(3):167-74. PubMed ID: 12196900
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives.
Sumiyoshi Y
Int J Clin Oncol; 2004 Dec; 9(6):484-90. PubMed ID: 15616879
[TBL] [Abstract][Full Text] [Related]
15. Selective organ preservation in muscle-invasive bladder cancer: review of the literature.
Khosravi-Shahi P; Cabezón-Gutiérrez L
Surg Oncol; 2012 Mar; 21(1):e17-22. PubMed ID: 22088598
[TBL] [Abstract][Full Text] [Related]
16. Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives.
Hafeez S; Huddart R
Expert Rev Anticancer Ther; 2014 Dec; 14(12):1429-43. PubMed ID: 25263197
[TBL] [Abstract][Full Text] [Related]
17. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
Koga F; Yoshida S; Kawakami S; Kageyama Y; Yokoyama M; Saito K; Fujii Y; Kobayashi T; Kihara K
Urology; 2008 Aug; 72(2):384-8. PubMed ID: 18455771
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
[TBL] [Abstract][Full Text] [Related]
19. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.
Smith ZL; Christodouleas JP; Keefe SM; Malkowicz SB; Guzzo TJ
BJU Int; 2013 Jul; 112(1):13-25. PubMed ID: 23356411
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer.
McHaffie DR; Kruser TJ; Gaston K; Mahoney J; Graham D; Haake M
Urol Oncol; 2016 Jun; 34(6):271-8. PubMed ID: 27108225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
